Stifel Financial Corp Bristol Myers Squibb CO Transaction History

Stifel Financial Corp

$85.8 Billion
Q1 2024

A detailed history of Stifel Financial Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stifel Financial Corp holds 1,918,007 shares of BMY stock, worth $79.7 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

1,918,007

Previous 1,571,302 22.06%

Holding current value

$79.7 Million

Previous $80.6 Million 29.01%

% of portfolio

0.12%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $16.6 Million - $18.9 Million	346,705 Added 22.06%	1,918,007 $104 Million
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $968,581 - $1.16 Million	-19,979 Reduced 1.26%	1,571,302 $80.6 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $14.7 Million - $16.5 Million	-254,419 Reduced 13.78%	1,591,281 $92.4 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $2.23 Million - $2.48 Million	-35,063 Reduced 1.86%	1,845,700 $118 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $5.93 Million - $6.73 Million	-90,312 Reduced 4.58%	1,880,763 $130 Million

Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $2.21 Million - $2.62 Million	32,271 Added 1.66%	1,971,075 $142 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $18,919 - $11.2 Million	145,536 Added 8.12%	1,938,804 $138 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $8 Million - $8.81 Million	-110,138 Reduced 5.79%	1,793,268 $138 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $8.22 Million - $9.85 Million	-133,675 Reduced 6.56%	1,903,406 $139 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $6.42 Million - $7.49 Million	-119,794 Reduced 5.55%	2,037,081 $127 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $5.26 Million - $6.16 Million	-88,868 Reduced 3.96%	2,156,875 $128 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $4.85 Million - $5.28 Million	-78,374 Reduced 3.37%	2,245,743 $150 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $3.77 Million - $4.23 Million	-63,451 Reduced 2.66%	2,324,117 $147 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $9.16 Million - $10.4 Million	-158,594 Reduced 6.23%	2,387,568 $148 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $214,271 - $237,440	-3,731 Reduced 0.15%	2,546,162 $154 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $11.2 Million - $13.1 Million	205,009 Added 8.74%	2,549,893 $150 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $10.4 Million - $15 Million	-223,190 Reduced 8.69%	2,344,884 $131 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $52.7 Million - $68.8 Million	1,071,207 Added 71.56%	2,568,074 $165 Million
Q3 2019 Nov 19, 2019	SELL	$42.77 - $50.71 $17,877 - $21,196	-418 Reduced 0.03%	1,496,867 $75.9 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $1.82 Million - $2.15 Million	42,494 Added 2.92%	1,497,285 $76 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $9.26 Million - $10.2 Million	207,454 Added 16.63%	1,454,791 $65.9 Million
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $15.2 Million - $18.1 Million	337,306 Added 37.07%	1,247,337 $59.5 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $1.63 Million - $2.11 Million	-33,359 Reduced 3.54%	910,031 $47.3 Million
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $4.39 Million - $4.95 Million	79,523 Added 9.21%	943,390 $58.5 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $3.48 Million - $4.34 Million	-68,835 Reduced 7.38%	863,867 $47.9 Million
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $9.31 Million - $10.7 Million	-155,424 Reduced 14.28%	932,702 $59 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $9.75 Million - $10.6 Million	162,613 Added 17.57%	1,088,126 $66.6 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $51.1 Million - $59 Million	925,513	925,513 $0

Others Institutions Holding BMY

# of Institutions

2,554

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $88.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Bristol Myers Squibb CO Transaction History